{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT05126758",
      "OrgStudyIdInfo": {
        "OrgStudyId": "CAP-1002-DMD-04"
      },
      "Organization": {
        "OrgFullName": "Capricor Inc.",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (HOPE-3)",
      "OfficialTitle": "A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Human Allogeneic Cardiosphere-Derived Cells for the Treatment of Duchenne Muscular Dystrophy",
      "Acronym": "HOPE-3"
    },
    "StatusModule": {
      "StatusVerifiedDate": "November 2021",
      "OverallStatus": "Not yet recruiting",
      "StartDateStruct": {
        "StartDate": "January 1, 2022",
        "StartDateType": "Anticipated"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "June 30, 2023",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "June 30, 2024",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "November 4, 2021",
      "StudyFirstSubmitQCDate": "November 16, 2021",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "November 19, 2021",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "November 16, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "November 19, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Capricor Inc.",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "Yes",
      "IsFDARegulatedDrug": "Yes",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "HOPE-3 is a multi-center, randomized, double-blind, placebo-controlled clinical trial evaluating the safety and efficacy of a cell therapy called CAP-1002 in study participants with Duchenne muscular dystrophy (DMD). Non-ambulatory and ambulatory boys and young men who meet eligibility criteria will be randomly assigned to receive either CAP-1002 or placebo every 3 months for a total of 4 doses during a 12-month period.",
      "DetailedDescription": "Upto 68 eligible study participants will be randomized to either CAP-1002 or placebo in a 1:1 ratio.\n\nThe trial will include visits at Screening, Baseline/Day 1, Week 4, and Months 3, 6, 9, and 12 with IV infusions of CAP-1002 or placebo on Day 1 and Months 3, 6, and 9.\nSafety evaluations will include adverse events, concomitant medications, physical exam, vital signs, 12-lead ECG, and clinical laboratory testing.\nEfficacy will be evaluated in the Performance of the Upper Limb, Egen Klassifikation Scale, North Star Ambulatory Assessment (ambulatory subjects only), 10 meter walk test (ambulatory subjects only), cardiac MRI, blood collection and quality of life."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Muscular Dystrophies",
          "Muscular Dystrophy, Duchenne",
          "Muscular Disorders, Atrophic",
          "Muscular Diseases",
          "Neuromuscular Diseases",
          "Genetic Diseases, X-Linked",
          "Genetic Diseases, Inborn",
          "Nervous System Diseases"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Duchenne Muscular Dystrophy",
          "Cell Therapy",
          "Performance of the Upper Limb",
          "Ambulatory",
          "Non-Ambulatory"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 3"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "Quadruple",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Care Provider",
              "Investigator",
              "Outcomes Assessor"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "68",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "CAP-1002",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "Patients will receive 150 million cardiosphere-derived cells (CDCs) via intravenous infusion every 3 months for a total of 4 doses.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: CAP-1002"
              ]
            }
          },
          {
            "ArmGroupLabel": "Placebo",
            "ArmGroupType": "Placebo Comparator",
            "ArmGroupDescription": "Patients will receive a placebo solution via intravenous infusion every 3 months for a total of 4 doses.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Drug: Placebo"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "CAP-1002",
            "InterventionDescription": "The active pharmaceutical ingredient in CAP-1002 is Cardiosphere-Derived Cells (CDCs). CDCs are known to secrete numerous bioactive elements (growth factors, exosomes) which impact the therapeutic benefits of the cell-based therapy. The mechanism of action is the composite ability to be immunomodulatory, anti-fibrotic and regenerative.\n\nOther Names:\n\nCardiosphere-Derived Cells\nCDCs",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "CAP-1002"
              ]
            }
          },
          {
            "InterventionType": "Drug",
            "InterventionName": "Placebo",
            "InterventionDescription": "Placebo",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Placebo"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "To evaluate full upper limb function at Month 12 following 4 IV administrations of CAP-1002",
            "PrimaryOutcomeDescription": "Mean change from baseline in full PUL 2.0 at Month 12",
            "PrimaryOutcomeTimeFrame": "At Month 12"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "To evaluate cardiac muscle function and structure at Month 12 following 4 IV administrations of CAP-1002",
            "SecondaryOutcomeDescription": "Mean change from baseline in ejection fraction at Month 12",
            "SecondaryOutcomeTimeFrame": "At Month 12"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nMale subjects at least 10 years of age at time of consent who are willing and able to provide informed consent to participate in the trial and diagnosed with DMD as confirmed by the Investigator\nGenetically confirmed DMD\nReduced ability to walk/run (if ambulatory)\nTreatment with systemic glucocorticoids for at least 12 months and at a stable dose at least 6 months prior to study participation, except for weight-based or toxicity-related adjustments\nCurrent and up-to-date immunizations\n\nExclusion Criteria:\n\nLeft ventricular ejection fraction (LVEF) < 35%\nElbow-flexion contractures > 30Â° in both extremities\nBody mass index (BMI) > 45\nPercent predicted forced vital capacity (FVC%) < 35%",
      "HealthyVolunteers": "No",
      "Gender": "Male",
      "MinimumAge": "10 Years",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Peter Stiegler",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "310.358.3046",
            "CentralContactEMail": "pstiegler@capricor.com"
          },
          {
            "CentralContactName": "Veena Ramanna",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "310.358.3046",
            "CentralContactEMail": "vramanna@capricor.com"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Craig McDonald, MD",
            "OverallOfficialAffiliation": "University of California, Davis",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "University of California, Davis",
            "LocationCity": "Sacramento",
            "LocationState": "California",
            "LocationZip": "95817",
            "LocationCountry": "United States",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Colleen Anthonisen",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "916-734-4307",
                  "LocationContactEMail": "canthonisen@ucdavis.edu"
                },
                {
                  "LocationContactName": "Craig McDonald, MD",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Undecided"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 21, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000009136",
            "ConditionMeshTerm": "Muscular Dystrophies"
          },
          {
            "ConditionMeshId": "D000020388",
            "ConditionMeshTerm": "Muscular Dystrophy, Duchenne"
          },
          {
            "ConditionMeshId": "D000009135",
            "ConditionMeshTerm": "Muscular Diseases"
          },
          {
            "ConditionMeshId": "D000020966",
            "ConditionMeshTerm": "Muscular Disorders, Atrophic"
          },
          {
            "ConditionMeshId": "D000009422",
            "ConditionMeshTerm": "Nervous System Diseases"
          },
          {
            "ConditionMeshId": "D000009468",
            "ConditionMeshTerm": "Neuromuscular Diseases"
          },
          {
            "ConditionMeshId": "D000030342",
            "ConditionMeshTerm": "Genetic Diseases, Inborn"
          },
          {
            "ConditionMeshId": "D000040181",
            "ConditionMeshTerm": "Genetic Diseases, X-Linked"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000009140",
            "ConditionAncestorTerm": "Musculoskeletal Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M11244",
            "ConditionBrowseLeafName": "Muscular Diseases",
            "ConditionBrowseLeafAsFound": "Muscular Diseases",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11245",
            "ConditionBrowseLeafName": "Muscular Dystrophies",
            "ConditionBrowseLeafAsFound": "Muscular Dystrophy",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11563",
            "ConditionBrowseLeafName": "Neuromuscular Diseases",
            "ConditionBrowseLeafAsFound": "Neuromuscular Diseases",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M3741",
            "ConditionBrowseLeafName": "Atrophy",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M21338",
            "ConditionBrowseLeafName": "Muscular Dystrophy, Duchenne",
            "ConditionBrowseLeafAsFound": "Muscular Dystrophy, Duchenne",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M22839",
            "ConditionBrowseLeafName": "Genetic Diseases, Inborn",
            "ConditionBrowseLeafAsFound": "Genetic Diseases",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M21850",
            "ConditionBrowseLeafName": "Muscular Disorders, Atrophic",
            "ConditionBrowseLeafAsFound": "Muscular Disorders, Atrophic",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M24030",
            "ConditionBrowseLeafName": "Genetic Diseases, X-Linked",
            "ConditionBrowseLeafAsFound": "Genetic Diseases, X-Linked",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11249",
            "ConditionBrowseLeafName": "Musculoskeletal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T3963",
            "ConditionBrowseLeafName": "Muscular Dystrophy",
            "ConditionBrowseLeafAsFound": "Muscular Dystrophy",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T698",
            "ConditionBrowseLeafName": "Becker Muscular Dystrophy",
            "ConditionBrowseLeafAsFound": "Duchenne",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T1945",
            "ConditionBrowseLeafName": "Duchenne Muscular Dystrophy",
            "ConditionBrowseLeafAsFound": "Duchenne Muscular Dystrophy",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC05",
            "ConditionBrowseBranchName": "Musculoskeletal Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC10",
            "ConditionBrowseBranchName": "Nervous System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC16",
            "ConditionBrowseBranchName": "Diseases and Abnormalities at or Before Birth"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M21013",
            "InterventionBrowseLeafName": "Pharmaceutical Solutions",
            "InterventionBrowseLeafRelevance": "low"
          },
          {
            "InterventionBrowseLeafId": "M11052",
            "InterventionBrowseLeafName": "Mitogens",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "PhSol",
            "InterventionBrowseBranchName": "Pharmaceutical Solutions"
          },
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}